(4151) – Corporate News
-
Ardelyx (ARDX) Announces Tenapanor for Hyperphosphatemia Approved in Japan
-
MEI Pharma (MEIP) and Kyowa Kirin Announce Discontinuation of Zandelisib Development Outside of Japan Following Recent FDA Meeting
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to 4151 Stock Lookup